NEW YORK, Sept. 13, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The […]
NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Perpetua Resources Corp (“Perpetua” or the “Company”) (NASDAQ: PPTA). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CrowdStrike Holdings, Inc. (“CrowdStrike” or the “Company”) (NASDAQ: CRWD). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX). Such investors are advised to contact Danielle Peyton at […]
NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (NASDAQ: HRMY). Such investors are advised to contact Danielle Peyton at [email protected] or […]
